You are part of your organization’s ML engineering team and notice that the accuracy of a model that was recently deployed into production is deteriorating.
What is the best first step address this?
Which of the following elements of feature engineering is most important to mitigate the potential bias in an Al system?
In procuring an AI system from a vendor, which of the following would be important to include in a contract to enable proper oversight and auditing of the system?
Which model is best for efficiency and agility, and tailored for lower-resource settings?
Why is it important that conformity requirements are satisfied before an AI system is released into production?
A company initially intended to use a large data set containing personal information to train an Al model. After consideration, the company determined that it can derive enough value from the data set without any personal information and permanently obfuscated all personal data elements before training the model.
This is an example of applying which privacy-enhancing technique (PET)?
CASE STUDY
Please use the following answer the next question:
A mid-size US healthcare network has decided to develop an Al solution to detect a type of cancer that is most likely arise in adults. Specifically, the healthcare network intends to create a recognition algorithm that will perform an initial review of all imaging and then route records a radiologist for secondary review pursuant agreed-upon criteria (e.g., a confidence score below a threshold).
To date, the healthcare network has taken the following steps: defined its Al ethical principles: conducted discovery to identify the intended uses and success criteria for the system: established an Al governance committee; assembled a broad, crossfunctional team with clear roles and responsibilities; and created policies and procedures to document standards, workflows, timelines and risk thresholds during the project.
The healthcare network intends to retain a cloud provider to host the solution and a consulting firm to help develop the algorithm using the healthcare network's existing data and de-identified data that is licensed from a large US clinical research partner.
In the design phase, what is the most important step for the healthcare network to take when mapping its existing data to the clinical research partner data?
CASE STUDY
Please use the following answer the next question:
A mid-size US healthcare network has decided to develop an Al solution to detect a type of cancer that is most likely arise in adults. Specifically, the healthcare network intends to create a recognition algorithm that will perform an initial review of all imaging and then route records a radiologist for secondary review pursuant Agreed-upon criteria (e.g., a confidence score below a threshold).
To date, the healthcare network has taken the following steps: defined its Al ethical principles: conducted discovery to identify the intended uses and success criteria for the system: established an Al governance committee; assembled a broad, crossfunctional team with clear roles and responsibilities; and created policies and procedures to document standards, workflows, timelines and risk thresholds during the project.
The healthcare network intends to retain a cloud provider to host the solution and a consulting firm to help develop the algorithm using the healthcare network's existing data and de-identified data that is licensed from a large US clinical research partner.
The most significant risk from combining the healthcare network’s existing data with the clinical research partner data is?
What is the main purpose of accountability structures under the Govern function of the NIST Al Risk Management Framework?
|
PDF + Testing Engine
|
|---|
|
$57.75 |
|
Testing Engine
|
|---|
|
$43.75 |
|
PDF (Q&A)
|
|---|
|
$36.75 |
IAPP Free Exams |
|---|
|